Загрузка...
Immune checkpoint pathways in non-small cell lung cancer
Immunotherapy has evolved at a phenomenal pace in cancer therapeutics. This has primarily been fueled by the much perceived necessity to procure an alternative to current standard of care chemotherapy agents, owing to several concerns such as treatment-related toxicity and poor long-term survival as...
Сохранить в:
| Опубликовано в: : | Ann Transl Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890048/ https://ncbi.nlm.nih.gov/pubmed/29666811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.09.30 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|